Abstract
The use of immunosuppressive agents has recently been raised during the COVID-19 pandemic to manage the COVID-19-induced systemic inflammatory response and improve mortality. This widespread use of steroids and other immunomodulators for severe COVID-19 diseases might pose a potential risk of reactivation of latent diseases and the emergence of opportunistic infections such as strongyloidiasis. We report a case of strongyloidiasis with cholestasis in a middle-aged man; who was otherwise healthy and had no history of recent travel, developed three weeks after a prolonged course of steroids for the management of severe COVID-19 pneumonia. The patient was managed with a combination of albendazole and ivermectin. A high index of suspicion of strongyloidiasis in symptomatic patients post immunosuppressant therapy for severe COVID-19 is required to prevent unfavorable outcomes. In selected high-risk patients, post prolonged steroid therapy for COVID-19 pneumonia screening for strongyloidiasis and ivermectin empirical treatment might be considered even in non-endemic areas.
Keywords
Publication details
- DOI
- 10.5001/omj.2023.31
- Journal
- Oman Medical Journal
- Publisher
- Oman Medical Specialty Board
- Open access
- Gold open access
Cite this article
APA 7
Al Busaidi, N., Al Farsi, F., Al Batashi, H., Kashoub, M. S., Al Sinani, A., Al Balushi, Z., & Khamis, F. (2023). Steroid-induced Strongyloidiasis with Cholestasis Post-COVID-19 Pneumonia. Oman Medical Journal. https://doi.org/10.5001/omj.2023.31
MLA 9
Al Busaidi, Noora, et al. "Steroid-induced Strongyloidiasis with Cholestasis Post-COVID-19 Pneumonia." Oman Medical Journal, 2023. https://doi.org/10.5001/omj.2023.31.
Chicago (author–date)
Al Busaidi, Noora, Fatma Al Farsi, Huda Al Batashi, Masoud Salim Kashoub, Ahmed Al Sinani, Zakariya Al Balushi, and Faryal Khamis. 2023. "Steroid-induced Strongyloidiasis with Cholestasis Post-COVID-19 Pneumonia." Oman Medical Journal. https://doi.org/10.5001/omj.2023.31.
Harvard
Al Busaidi, N., Al Farsi, F., Al Batashi, H., Kashoub, M. S., Al Sinani, A., Al Balushi, Z. and Khamis, F. (2023) 'Steroid-induced Strongyloidiasis with Cholestasis Post-COVID-19 Pneumonia', Oman Medical Journal. doi:10.5001/omj.2023.31.
Vancouver
Al Busaidi N, Al Farsi F, Al Batashi H, Kashoub MS, Al Sinani A, Al Balushi Z, et al. Steroid-induced Strongyloidiasis with Cholestasis Post-COVID-19 Pneumonia. Oman Medical Journal. 2023. doi:10.5001/omj.2023.31
IEEE
N. Al Busaidi, F. Al Farsi, H. Al Batashi, M. S. Kashoub, A. Al Sinani, Z. Al Balushi, and F. Khamis, "Steroid-induced Strongyloidiasis with Cholestasis Post-COVID-19 Pneumonia," Oman Medical Journal, 2023, doi: 10.5001/omj.2023.31.